The escalating potency of street fentanyl has created uncertainty about whether standard naloxone doses can reliably reverse life-threatening overdoses. This controlled study reveals concerning gaps in recovery patterns that could affect emergency response protocols. Researchers deliberately induced moderate respiratory depression in 30 volunteers using fentanyl and sufentanil infusions, then administered 4mg intranasal naloxone to measure reversal effectiveness. The study included both opioid-naive individuals and daily users consuming up to 2,250mg morphine equivalents daily. While naloxone restored breathing volume within 2-4 minutes across all participants, carbon dioxide clearance lagged significantly behind at 11-17 minutes. More troubling, sufentanil completely blocked CO2 recovery in several participants—4 opioid-naive subjects and 8 daily users showed no normalization of blood chemistry despite restored breathing patterns. This disconnect between mechanical breathing restoration and metabolic recovery suggests naloxone's protective window may be narrower than previously understood, particularly against ultra-high-potency synthetics. The finding challenges assumptions about overdose reversal completeness and timing. Current naloxone protocols assume breathing restoration indicates full reversal, but this data suggests continued physiological stress even after apparent recovery. The delayed CO2 clearance could explain why some overdose victims experience secondary complications or require multiple naloxone doses. For harm reduction programs and emergency responders, these results underscore the importance of extended monitoring periods and potential need for higher naloxone doses against synthetic opioids. The research provides crucial pharmacokinetic data for updating treatment guidelines as the overdose crisis increasingly involves ultra-potent synthetic compounds.